Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing

Loading news article.

Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing | WAPE

Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing

Article summary

Related companies

Comments —